Understand FDA stability testing requirements for generic drugs. Learn about ICH Q1A(R2) guidelines, ANDA submission data needs, common pitfalls, and future regulatory changes for pharmaceutical manufacturers.
Explore the legal and regulatory requirements of the ANDA process for generic drug approval. Learn about Hatch-Waxman, bioequivalence, patent certifications, and FDA fees.
The Hatch-Waxman Act balances brand patent protection with generic drug competition. Learn how the ANDA process, Orange Book listings, and 180-day exclusivity rules drive down medication costs for millions of Americans.